Knockdown of liver-intestine cadherin decreases BGC823 cell invasiveness and metastasis in vivo

World Journal of Gastroenterology

Volumn 18, Issue 24, 2012, Pages 3129-3137

  Xu, Yu ^a   Zhang, Jin ^a   Liu, Qi Sheng ^b   Dong, Wei Guo ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Department of Gastroenterology   (China)

Author keywords

Cadherin; Gastric cancer; Intratumoral administration; Liver; Orthotopic implantation; Proteomics

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALPHA ENOLASE; ALPHA TROPOMYOSIN; BETA TUBULIN; CADHERIN; CHAPERONE; CLATHRIN LIGHT CHAIN; CYTOSKELETON PROTEIN; GLUTATHIONE TRANSFERASE; HEAT SHOCK PROTEIN; INTERLEUKIN 1ALPHA; LENTIVIRUS VECTOR; LIVER INTESTINE CADHERIN; PYRUVATE KINASE; RNA; UNCLASSIFIED DRUG; VINCULIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GENE THERAPY; CANCER GROWTH; CANCER INFILTRATION; CANCER INVASION; CANCER REGRESSION; CELL CYCLE; CELL DIFFERENTIATION; CELL METABOLISM; CELL PROLIFERATION; CELL STRAIN BGC823; CONTROLLED STUDY; DOWN REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNITY; IN VIVO STUDY; LIVER METASTASIS; LUNG METASTASIS; METASTASIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEOMICS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STOMACH CANCER; TANDEM MASS SPECTROMETRY; TUMOR VOLUME; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 84863905917     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v18.i24.3129     Document Type: Article

References (34)

1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in differ en t geographic regions of the world. J Clin Oncol 2006; 24: 2137-2150
2. Sawada K, Mitra AK, Radjabi AR, Bhaskar V, Kistner EO, Tretiakova M, Jagadee swaran S, Montag A, Becker A, Kenny HA, Peter ME, Ramakrishnan V, Yamada SD, Lengyel E. Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeu tic target. Cancer Res 2008; 68: 2329-2339
3. Birchmeier W, Behren s J. Cadherin expression in carcino mas: role in the formation of cell junctions and the preven tion of invasivene ss. Biochim Biophys Acta 1994; 1198: 11-26
4. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 1993; 5: 806-811
5. Hirohashi S, Kanai Y. Cell adhesion system and human cancer morphogene sis. Cancer Sci 2003; 94: 575-581
6. Gessner R, Tauber R. Intestinal cell adhesion molecules. Liver-intestine cadherin. Ann N Y Acad Sci 2000; 915: 136-143
7. Kreft B, Berndorff D, Böttinger A, Finnemann S, Wedlich D, Hortsch M, Tauber R, Gessner R. LI-cadherin-mediated cellcell adhesion does not require cytoplasmic interactions. J Cell Biol 1997; 136: 1109-1121
8. Grötzinger C, Kneifel J, Patschan D, Schnoy N, Anagnosto poulos I, Faiss S, Tauber R, Wiedenmann B, Gessner R. LIcadherin: a marker of gastric metaplasia and neoplasia. Gut 2001; 49: 73-81
9. Ito R, Oue N, Yoshida K, Kunimitsu K, Nakayama H, Nakachi K, Yasui W. Clinicopathological significant and prog nostic influence of cadherin-17 expression in gastric cancer. Virchows Arch 2005; 447: 717-722
10. Dong W, Yu Q, Xu Y. Altered expression of a Li-cadherin in gastric cancer and intestinal metaplasia. Dig Dis Sci 2007; 52: 536-542
11. Dong WG, Yu QF, Xu Y, Fan LF. Li-cadherin is inversely correlated with galectin-3 expression in gastric cancer. Dig Dis Sci 2008; 53: 1811-1817
12. Liu QS, Zhang J, Liu M, Dong WG. Len tiviral-mediated miRNA against liver-intestine cadherin suppresses tumor growth and invasivene ss of human gastric cancer. Cancer Sci 2010; 101: 1807-1812
13. Kerbel RS. Human tumor xen ografts as predictive preclini cal models for anticancer drug activity in humans: better than commonly perceived-but they can be improved. Cancer Biol Ther 2003; 2: S134-S139
14. Onn A, Isobe T, Itasaka S, Wu W, O'Reilly MS, Kihong W, Fidler IJ, Herbst RS. Developmen t of an orthotopic model to study the biology and therapy of primary human lung can cer in nude mice. Clin Cancer Res 2003; 9: 5532-5539
15. Takahashi T, Morotomi M, Nomoto K. A novel mouse model of rectal cancer established by orthotopic implanta tion of colon cancer cells. Cancer Sci 2004; 95: 514-519
16. Morris KV, Rossi JJ. Len tiviral-mediated delivery of siR NAs for antiviral therapy. Gene Ther 2006; 13: 553-558
17. Orlacchio A, Bernardi G, Orlacchio A, Martino S. RNA interferen ce as a tool for Alzheimer's disease therapy. Mini Rev Med Chem 2007; 7: 1166-1176
18. Lundberg C, Björklund T, Carlsson T, Jakobsson J, Hantraye P, Déglon N, Kirik D. Applications of len tiviral vectors for biology and gene therapy of neu rological disorders. Curr Gene Ther 2008; 8: 461-473
19. Maeda Y, Sheffield AM, Smith RJ. Therapeu tic regulation of gene expression in the inner ear using RNA interferen ce. Adv Otorhinolaryngol 2009; 66: 13-36
20. Fumoto S, Nishi J, Nakamura J, Nishida K. Gene therapy for gastric diseases. Curr Gene Ther 2008; 8: 187-200
21. Liu LX, Lee NP, Chan VW, Xue W, Zender L, Zhang C, Mao M, Dai H, Wang XL, Xu MZ, Lee TK, Ng IO, Chen Y, Kung HF, Lowe SW, Poon RT, Wang JH, Luk JM. Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma. Hepatology 2009; 50: 1453-1463
22. Nishigaki R, Osaki M, Hiratsuka M, Toda T, Murakami K, Jeang KT, Ito H, Inoue T, Oshimura M. Proteomic iden tification of differentially-expressed genes in human gastric carcinomas. Proteomics 2005; 5: 3205-3213
23. Sickmann A, Mreyen M, Meyer HE. Identification of modi fied proteins by mass spectrometry. IUBMB Life 2002; 54: 51-57
24. Takamura M, Sakamoto M, Ino Y, Shimamura T, Ichida T, Asakura H, Hirohashi S. Expression of liver-intestine cad herin and its possible interaction with galectin-3 in ductal aden ocarcinoma of the pancreas. Cancer Sci 2003; 94: 425-430
25. Su MC, Yuan RH, Lin CY, Jeng YM. Cadherin-17 is a useful diagnostic marker for aden ocarcinomas of the digestive sys tem. Mod Pathol 2008; 21: 1379-1386
26. Takamura M, Yamagiwa S, Wakai T, Tamura Y, Kamimura H, Kato T, Tsuchiya A, Matsuda Y, Shirai Y, Ichida T, Ajioka Y, Aoyagi Y. Loss of liver-intestine cadherin in human in trahepatic cholangiocarcinoma promotes angiogene sis by up-regulating metal-responsive transcription factor-1 and placen tal growth factor. Int J Oncol 2010; 36: 245-254
27. Zheng X, Hong L, Shi L, Guo J, Sun Z, Zhou J. Proteomics analysis of host cells infected with infectious bursal disease virus. Mol Cell Proteomics 2008; 7: 612-625
28. Zhu K, Zhao J, Lubman DM, Miller FR, Barder TJ. Protein pI shifts due to posttranslational modifications in the sepa ration and characterization of proteins. Anal Chem 2005; 77: 2745-2755
29. Yasui W, Oue N, Sentani K, Sakamoto N, Motoshita J. Tran scriptome dissection of gastric cancer: identification of novel diagnostic and therapeu tic targets from pathology specimen s. Pathol Int 2009; 59: 121-136
30. Lee HJ, Nam KT, Park HS, Kim MA, Lafleur BJ, Aburatani H, Yang HK, Kim WH, Goldenring JR. Gene expression profil ing of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer. Gastroenterology 2010; 139: 213-25.e3
31. Celis JE, Gromov P. Proteomics in translational cancer re search: toward an integrated approach. Cancer Cell 2003; 3: 9-15
32. Rabilloud T. Two-dimen sional gel electrophoresis in pro teomics: old, old fashioned, but it still climbs up the moun tains. Proteomics 2002; 2: 3-10
33. Sickmann A, Mreyen M, Meyer HE. Mass spectrometry-a key technology in proteome research. Adv Biochem Eng Biotechnol 2003; 83: 141-176
34. Schuchardt S, Sickmann A. Protein iden tification using mass spectrometry: a method overview. EXS 2007; 97: 141-170